top of page

Journal Club: LUBAC accelerates B-cell lymphomagenesis by conferring B cells resistance to genotoxic

Key Points

  • LUBAC accelerates B-cell lymphomagenesis through protection of DNA damage-induced apoptosis, thereby promoting AID-mediated mutations.

  • Inhibition of LUBAC by small molecules is a promising therapeutic strategy for B-cell lymphomas with NF-kB activation.

bottom of page